Etoposide/Ifosfamide/Mesna/Mitoxantrone/Rituximab Regimen

Preferred Label : Etoposide/Ifosfamide/Mesna/Mitoxantrone/Rituximab Regimen;

NCIt synonyms : MINE Plus Rituximab Regimen; Etoposide/Ifosfamide/Mesna/Mitoxantrone/Rituximab; Etoposide-Ifosfamide-Mesna-Mitoxantrone-Rituximab; R-MINE; MINE-R; Rituxan Plus MINE; Mesna/Ifosfamide/Mitoxantrone/Etoposide Plus Rituximab;

NCIt definition : A regimen consisting of etoposide, ifosfamide, mesna, mitoxantrone and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).;

NCI Metathesaurus CUI : CL1926314;

Details

Origin ID

C204004;

UMLS CUI

C5891085;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Etoposide [NCIt concept]
- Ifosfamide [NCIt concept]
- Mesna [NCIt concept]
- Mitoxantrone [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients